Skip to content
HomeLatest newsInnovationSkin-Flex™: The new BAND-AID® Brand bandages that stay on for 24 hours
Customer reading on tablet with Skin Flex Band-AID on her right index finger

Skin-Flex™: The new BAND-AID® Brand bandages that stay on for 24 hours

Through hand-washing, phone-scrolling, treadmill-running, baby-chasing and whatever else your busy day has you doing, these bandages are designed to stay put for a full 24 hours.

Share Article
share to

Covering up cuts and scrapes just got a whole lot more comfortable, thanks to the new Skin-Flex™ line of adhesive bandages.

The latest BAND-AID® Brand product, now available in drugstores, is designed to act just like a second skin—the super-flexible bandages are made from touch screen-friendly material, so they won’t get in the way when you’re using your smartphone or tablet.

A box of Skin-FLex Finger BAND-AIDs

Nor will they get soggy or fall off: Skin-Flex™ bandages have lightweight cross-fiber technology that allows for almost instant drying, and the advanced adhesive stays on a full 24 hours—even through hand-washing.

“Our goal was to develop a bandage that moves with every movement the wearer makes, while being as durable as possible,” explains Melinda Cettina, Director of Global Wound Care Research & Development at Johnson & Johnson Consumer Inc. “We came up with an adhesive and material system that did just that. It’s lightweight, so the wearer can hardly feel the bandage, and it is really stretchable and flexible, just like your skin.”

Basically, you’ll forget you’re wearing a bandage, so it’s easier to get on with life—and scrolling through those social feeds.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.